Grace Therapeutics, Inc. (GRCE)
Market Open
26 Oct, 06:41 PM
NASDAQ (CM) NASDAQ (CM) Primary $
1. 77
-0.16
-8.2902%
$
32.22M Market Cap
- P/E Ratio
- Div Yield
446,181 Volume
0 Eps
$ 1.93
Previous Close Want to track GRCE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Grace Therapeutics, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| NA Nizar Araji National Bank Of Canada /FI/ | 2,680 | $10,023.2 | $5,038.4 | -$4,984.8 | -49.73% |
| DS Danny Salinas Cantor Fitzgerald LP | 100,000 | $233,000 | $195,000 | -$38,000 | -16.31% |
 Sima Elimelech Activest Wealth Management | 104 | $388.96 | $199.68 | -$189.28 | -48.66% |
| MA Marie-Andree Alain Federation des caisses Desjardins du Quebec | 41 | $94.48 | $80.15 | -$14.33 | -15.17% |
2026 © Marketlog. All Rights Reserved.
